Use and abuse of taxanes in the management of metastatic breast cancer

Author： Bernard-Marty C. Cardoso F. Piccart M.J.

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.39, Iss.14, 2003-09, pp. : 1978-1989

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of taxanes in early breast cancer

By Hudis C.

EJC Supplements, Vol. 1, Iss. 7, 2003-10 ,pp. : 1-10

Elsevier

Access to resources Recommend Favorite

Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer

By Schwartzberg Lee Cobb Patrick Walker Mark Stepanski Edward Houts Arthur

Supportive Care in Cancer, Vol. 17, Iss. 8, 2009-08 ,pp. : 1081-1088

Springer Publishing Company

Access to resources Recommend Favorite

Examination of the use of Exemestane in patients with metastatic breast cancer

By Takashima Seiki

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 189-194

Springer Publishing Company

Access to resources Recommend Favorite

SEOM clinical guidelines for the management of metastatic breast cancer 2013

By Llombart Cussac A. Haba Rodríguez J. Ruiz Simón A. Álvarez López I. Cortés Castán J.

Clinical and Translational Oncology, Vol. 15, Iss. 12, 2013-12 ,pp. : 1004-1010

Springer Publishing Company

Access to resources Recommend Favorite

Metastatic view of breast cancer

By Banfalvi Gaspar

Cancer and Metastasis Reviews, Vol. 31, Iss. 3-4, 2012-12 ,pp. : 815-822

Springer Publishing Company

Access to resources Recommend Favorite